#BEGIN_DRUGCARD DB04120

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
452-86-8

# ChEBI_ID:
17254

# Chemical_Formula:
C7H8O2

# Chemical_IUPAC_Name:
4-methylbenzene-1,2-diol

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Antioxidants
Carcinogens
Neuroprotective Agents

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
1.37

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
4-Methyl-1,2-Benzenediol

# HET_ID:
MCT

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C7H8O2/c1-5-2-3-6(8)7(9)4-5/h2-4,8-9H,1H3

# InChI_Key:
InChIKey=ZBCATMYQYDCTIZ-UHFFFAOYSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
C06730

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
4120

# Mechanism_Of_Action:
Not Available

# Melting_Point:
65 Â°C

# Molecular_Weight_Avg:
124.1372

# Molecular_Weight_Mono:
124.0524295

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1L4G

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
1.02

# Predicted_LogS:
-0.52

# Predicted_Water_Solubility:
3.79e+01 g/l

# Primary_Accession_No:
DB04120

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
9958

# PubChem_Substance_ID:
46507108

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT02138

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
CC1=CC=C(O)C(O)=C1

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:22:58 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
L35477

# Drug_Target_1_GenBank_ID_Protein:
535767

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
cobT

# Drug_Target_1_Gene_Sequence:
>1101 bp
ATGAGCCGATTATTACGGACGAGACATCTTATGCAGACACTACACGCTTTACTCCGTGAC
ATTCCTGCGCCGGACGCCGAGGCGATGGCGCGTACGCAGCAACATATTGACGGCCTGCTC
AAACCGCCGGGCAGCCTGGGCAGACTGGAAACCTTAGCCGTTCAGCTCGCGGGTATGCCG
GGTCTTAACGGTACGCCGCAGGTAGGTGAAAAGGCGGTGCTGGTGATGTGCGCCGACCAT
GGCGTCTGGGATGAAGGCGTAGCGGTTTCGCCCAAAATCGTGACGGCGATTCAGGCGGCG
AATATGACGCGGGGAACAACCGGCGTATGCGTGCTTGCCGCTCAGGCCGGTGCGAAGGTG
CATGTCATTGATGTCGGTATTGATGCCGAACCTATTCCTGGCGTAGTTAATATGCGCGTC
GCGCGCGGCTGCGGAAATATTGCCGTTGGCCCGGCGATGAGTCGCTTGCAGGCTGAGGCG
CTTTTACTGGAGGTTTCCCGCTGCGCCTGCGACCTGGCGCAACGCGGCGTGACCTTATTT
GGCGTAGGGGAACTGGGAATGGCGAACACTACGCCAGCCGCCGCGATGGTCAGCGTTTTT
ACAGGAAGTGATGCAAAAGAGGTGGTGGGGATTGGCGCGAATCTTCCGCCTTCCCGCATC
GATAATAAAGTGGACGTCGTGCGGCGGGCGATTGCGATTAATCAGCCCAATCCGCGCGAC
GGCATTGATGTGTTGTCGAAGGTGGGTGGTTTTGATCTGGTCGGGATGACCGGCGTGATG
CTTGGCGCGGCAAGGTGTGGCTTACCCGTATTGCTGGATGGCTTTCTTTCCTACTCGGCA
GCGCTGGCGGCCTGTCAGATTGCGCCTGCGGTGAGACCTTATCTGATCCCGTCGCACTTT
TCGGCGGAAAAGGGCGCCCGCATCGCGCTCGCGCATTTGTCTATGGAACCCTATTTGCAT
ATGGCGATGCGGTTAGGTGAAGGAAGCGGCGCGGCGCTGGCGATGCCGATCGTGGAAGCC
GCGTGCGCCATGTTCCACAACATGGGGGAGTTGGCGGCCAGTAATATTGTCCTGCCGGAG
GGGAACGCAAACGCAACATAA

# Drug_Target_1_General_Function:
Coenzyme transport and metabolism

# Drug_Target_1_General_References:
10587435	Cheong CG, Escalante-Semerena JC, Rayment I: The three-dimensional structures of nicotinate mononucleotide:5,6- dimethylbenzimidazole phosphoribosyltransferase (CobT) from Salmonella typhimurium complexed with 5,6-dimethybenzimidazole and its reaction products determined to 1.9 A resolution. Biochemistry. 1999 Dec 7;38(49):16125-35.
11677609	McClelland M, Sanderson KE, Spieth J, Clifton SW, Latreille P, Courtney L, Porwollik S, Ali J, Dante M, Du F, Hou S, Layman D, Leonard S, Nguyen C, Scott K, Holmes A, Grewal N, Mulvaney E, Ryan E, Sun H, Florea L, Miller W, Stoneking T, Nhan M, Waterston R, Wilson RK: Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature. 2001 Oct 25;413(6858):852-6.
7883701	Chen P, Ailion M, Weyand N, Roth J: The end of the cob operon: evidence that the last gene (cobT) catalyzes synthesis of the lower ligand of vitamin B12, dimethylbenzimidazole. J Bacteriol. 1995 Mar;177(6):1461-9.
8501034	Roth JR, Lawrence JG, Rubenfield M, Kieffer-Higgins S, Church GM: Characterization of the cobalamin (vitamin B12) biosynthetic genes of Salmonella typhimurium. J Bacteriol. 1993 Jun;175(11):3303-16.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2264

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
36613

# Drug_Target_1_Name:
Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase

# Drug_Target_1_Number_of_Residues:
356

# Drug_Target_1_PDB_ID:
1L5O

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF02277	DBI_PRT

# Drug_Target_1_Protein_Sequence:
>Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase
MQTLHALLRDIPAPDAEAMARAQQHIDGLLKPPGSLGRLETLAVQLAGMPGLNGTPQVGE
KAVLVMCADHGVWDEGVAVSPKIVTAIQAANMTRGTTGVCVLAAQAGAKVHVIDVGIDAE
PIPGVVNMRVARGCGNIAVGPAMSRLQAEALLLEVSRYTCDLAQRGVTLFGVGELGMANT
TPAAAMVSVFTGSDAKEVVGIGANLPPSRIDNKVDVVRRAIAINQPNPRDGIDVLSKVGG
FDLVGMTGVMLGAARCGLPVLLDGFLSYSAALAACQIAPAVRPYLIPSHFSAEKGARIAL
AHLSMEPYLHMAMRLGEGSGAALAMPIVEAACAMFHNMGELAASNIVLPEGNANAT

# Drug_Target_1_Reaction:
beta-nicotinate D-ribonucleotide + 5,6-dimethylbenzimidazole = nicotinate + alpha-ribazole 5'-phosphate

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Catalyzes the synthesis of alpha-ribazole-5'-phosphate from nicotinate mononucleotide (NAMN) and 5,6- dimethylbenzimidazole (DMB)

# Drug_Target_1_SwissProt_ID:
Q05603

# Drug_Target_1_SwissProt_Name:
COBT_SALTY

# Drug_Target_1_Synonyms:
EC 2.4.2.21
N(1)-alpha-phosphoribosyltransferase
NN:DBI PRT

# Drug_Target_1_Theoretical_pI:
6.30

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Not Available

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
AF009224

# Drug_Target_2_GenBank_ID_Protein:
2996611

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
catA

# Drug_Target_2_Gene_Sequence:
>936 bp
ATGGAAGTTAAAATATTCAATACTCAGGATGTGCAAGATTTTTTACGTGTTGCAAGCGGA
CTTGAGCAAGAAGGTGGCAATCCGCGTGTAAAGCAGATCATCCATCGTGTGCTTTCAGAT
TTATATAAAGCCATTGAAGATTTGAATATCACTTCAGATGAATACTGGGCAGGTGTGGCA
TATTTAAATCAGCTAGGTGCCAATCAAGAAGCTGGTTTACTCTCGCCAGGCTTGGGTTTT
GACCATTACCTCGATATGCGTATGGATGCCGAAGATGCCGCACTAGGTATTGAAAATGCG
ACACCACGTACCATTGAAGGCCCGCTATACGTGGCAGGTGCGCCTGAATCGGTAGGTTAT
GCGCGCATGGATGACGGAAGTGATCCAAATGGTCATACCCTGATTCTACATGGCACGATC
TTTGATGCAGATGGAAAACCTTTACCCAATGCCAAAGTTGAAATCTGGCATGCCAATACC
AAAGGCTTTTATTCACACTTCGACCCAACAGGCGAGCAGCAGGCGTTCAATATGCGCCGT
AGTATTATTACCGATGAAAACGGTCAGTATCGCGTTCGTACCATTTTGCCTGCGGGTTAT
GGTTGCCCACCAGAAGGTCCAACGCAACAGTTGCTGAATCAGTTGGGCCGTCATGGTAAC
CGCCCTGCGCACATTCACTATTTTGTTTCTGCCGATGGACACCGCAAACTAACTACGCAA
ATTAATGTGGCTGGCGATCCGTACACCTATGACGACTTTGCTTATGCAACCCGTGAAGGC
TTGGTGGTTGATGCAGTGGAACACACCGATCCTGAAGCCATTAAGGCCAATGATGTTGAA
GGCCCATTCGCTGAAATGGTTTTCGATCTAAAATTGACGCGTTTGGTTGATGGTGTAGAT
AACCAAGTTGTTGATCGTCCACGTCTAGCGGTGTAA

# Drug_Target_2_General_Function:
Secondary metabolites biosynthesis, transport and catabolism

# Drug_Target_2_General_References:
10801478	Vetting MW, Ohlendorf DH: The 1.8 A crystal structure of catechol 1,2-dioxygenase reveals a novel hydrophobic helical zipper as a subunit linker. Structure. 2000 Apr 15;8(4):429-40.
3170486	Neidle EL, Hartnett C, Bonitz S, Ornston LN: DNA sequence of the Acinetobacter calcoaceticus catechol 1,2-dioxygenase I structural gene catA: evidence for evolutionary divergence of intradiol dioxygenases by acquisition of DNA sequence repetitions. J Bacteriol. 1988 Oct;170(10):4874-80.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
2658

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
34348

# Drug_Target_2_Name:
Catechol 1,2-dioxygenase

# Drug_Target_2_Number_of_Residues:
311

# Drug_Target_2_PDB_ID:
1DMH

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF00775	Dioxygenase_C
PF04444	Dioxygenase_N

# Drug_Target_2_Protein_Sequence:
>Catechol 1,2-dioxygenase
MEVKIFNTQDVQDFLRVASGLEQEGGNPRVKQIIHRVLSDLYKAIEDLNITSDEYWAGVA
YLNQLGANQEAGLLSPGLGFDHYLDMRMDAEDAALGIENATPRTIEGPLYVAGAPESVGY
ARMDDGSDPNGHTLILHGTIFDADGKPLPNAKVEIWHANTKGFYSHFDPTGEQQAFNMRR
SIITDENGQYRVRTILPAGYGCPPEGPTQQLLNQLGRHGNRPAHIHYFVSADGHRKLTTQ
INVAGDPYTYDDFAYATREGLVVDAVEHTDPEAIKANDVEGPFAEMVFDLKLTRLVDGVD
NQVVDRPRLAV

# Drug_Target_2_Reaction:
catechol + O2 = cis,cis-muconate

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
Catechol + O(2) = cis,cis-muconate

# Drug_Target_2_SwissProt_ID:
P07773

# Drug_Target_2_SwissProt_Name:
CATA_ACIAD

# Drug_Target_2_Synonyms:
1,2-CTD
EC 1.13.11.1

# Drug_Target_2_Theoretical_pI:
4.60

# Drug_Target_2_Transmembrane_Regions:
None

#END_DRUGCARD DB04120
